TABLE 1.
Bacterial strains used in this study
| Strain | Descriptiona | Source or reference |
|---|---|---|
| C. fetus subsp. fetus ATCC 27374 | Type strain, Nalr | ATCC |
| C. fetus subsp. fetus BT 10/98 | Sheep isolate, Nalr | J. Wagenaarb |
| C. fetus subsp. fetus BT 34/99 | Bovine isolate, aborted fetus, Nalr | J. Wagenaar |
| C. fetus subsp. fetus F12 | Human isolate, septicemia, Austria, Cipr Nalr | 26 |
| C. fetus subsp. venerealis ATCC 19438 | Type strain, Nalr | ATCC |
| C. fetus subsp. venerealis v311 | Animal isolate, Nalr | J. Wagenaar |
| C. fetus subsp. venerealis 4111/108 | Bovine isolate, infected bull, Australia, Nalr | 24 |
| C. jejuni H02/52 | Human isolate, diarrhea, no plasmid, Nalr | G. Feierlc |
| C. jejuni B02/55 | Human isolate, diarrhea, no plasmid, Nalr Kmr | G. Feierl |
| E. coli DH5α | endA1 recA1 gyrA96 thi-l hsdR17 supE44 λ−relA1 deoR Δ(lacZYA-argF)-U169 φ80dlacZΔ(M15) | 62 |
| E. coli S17-1 λpir | Tpr SmrrecA thi pro hsdR−M+ RP4:2-Tc:Mu:Km Tn7 λ pir | 12 |
a
Nalr, nalidixic acid resistance phenotype; Cipr, ciprofloxacin resistance phenotype; Smr, streptomycin resistance phenotype; Tpr, trimethoprim resistance phenotype.
b
Department of Infectious Disease and Immunology, Utrecht University.
c
Institute of Hygiene, Medical University Graz.